(Q26765038)

4

Nathalie Costedoat-Chalumeau

Rebecca Fischer-Betz

0 references

10

Nathalie Costedoat-Chalumeau

0 references

Carina Götestam Skorpen

Carina Götestam Skorpen

1

0 references

Guillermo Ruiz-Irastorza

Guillermo Ruiz-Irastorza

14

0 references

Irene Cetin

Irene Cetin

9

0 references

Jiří Vencovský

Jiri Vencovsky

16

0 references

Angela Tincani

3

Angela Tincani

0 references

Munther A. Khamashta

13

Munther Khamashta

0 references

Maurizio Cutolo

17

French Vasculitis Study Group

Maurizio Cutolo

0 references

1 reference

ORCID Public Data File 2021

Christina D Chambers

6

Christina Chambers

0 references

Radboud J E M Dolhain

11

Radboud Dolhain

0 references

Frauke Förger

12

Frauke Förger

0 references

Monika Ostensen

20

Monika Østensen

0 references

author name string

Rebecca Fischer-Betz

4

0 references

Elisabeth Elefant

5

0 references

Josè da Silva

7

0 references

Catherine Nelson-Piercy

8

0 references

Angela Zink

15

0 references

Nele Caeyers

18

0 references

Claudia Zumbühl

Annals of the Rheumatic Diseases

19

0 references

language of work or name

English

0 references

publication date

May 2016

0 references

published in

0 references

volume

75

0 references

issue

5

0 references

page(s)

795-810

0 references

cites work

Anti-inflammatory and immunosuppressive drugs and reproduction

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Updated method guidelines for cochrane musculoskeletal group systematic reviews and metaanalyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

The levels of evidence and their role in evidence-based medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Understanding GRADE: an introduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Effects of ibuprofen, diclofenac, naproxen, and piroxicam on the course of pregnancy and pregnancy outcome: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Periconceptional over-the-counter nonsteroidal anti-inflammatory drug exposure and risk for spontaneous abortion

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Exposure to non-steroidal anti-inflammatory drugs during pregnancy and the risk of selected birth defects: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Fetal exposure to nonsteroidal anti-inflammatory drugs and spontaneous abortions

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Major malformations following exposure to nonsteroidal antiinflammatory drugs during the first trimester of pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150,000 pregnant women and expectant fathers

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Use of nonaspirin nonsteroidal anti-inflammatory drugs during pregnancy and the risk of spontaneous abortion

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Pregnancy outcome in 396 pregnancies in patients with SLE in Saudi Arabia

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Use of Corticosteroids in Early Pregnancy is Not Associated With Risk of Oral Clefts and Other Congenital Malformations in Offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Combined oral prednisolone and heparin versus heparin: the effect on peripheral NK cells and clinical outcome in patients with unexplained recurrent miscarriage. A double-blind placebo randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Corticosteroid use during pregnancy and risk of orofacial clefts

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

A feasibility trial of screening women with idiopathic recurrent miscarriage for high uterine natural killer cell density and randomizing to prednisolone or placebo when pregnant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Pregnancy outcome following in utero exposure to hydroxychloroquine: a prospective comparative observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Hydroxychloroquine in lupus pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Hydroxychloroquine and pregnancy on lupus flares in Korean patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: results of a national prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Birth outcomes in women who have taken leflunomide during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Limited risks of major congenital anomalies in children of mothers with IBD and effects of medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Early pregnancy azathioprine use and pregnancy outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Influence of medical treatment, smoking and disease activity on pregnancy outcomes in Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Birth outcome in women treated with azathioprine or mercaptopurine during pregnancy: A Danish nationwide cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Pregnancy outcomes in liver and cardiothoracic transplant recipients: a UK national cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Long-term neurodevelopment of children exposed in utero to ciclosporin after maternal renal transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Pregnancy outcomes after kidney transplantation-immunosuppressive therapy comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Pregnancy outcomes in women with familial Mediterranean fever receiving colchicine: is amniocentesis justified?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Pregnancy outcome after in utero exposure to colchicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Pregnancy outcome in women with antiphospholipid antibodies: report on a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-α therapy during pregnancy: three-center study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Pregnancy outcome following gestational exposure to TNF-alpha-inhibitors: a prospective, comparative, observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Pregnancy outcome after TNF-α inhibitor therapy during the first trimester: a prospective multicentre cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Effects of discontinuing anti-tumor necrosis factor therapy during pregnancy on the course of inflammatory bowel disease and neonatal exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Importance of neonatal FcR in regulating the serum half-life of therapeutic proteins containing the Fc domain of human IgG1: a comparative study of the affinity of monoclonal antibodies and Fc-fusion proteins to human neonatal FcR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Prospective evaluation of a model for the prediction of milk:plasma drug concentrations from physicochemical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Methotrexate embryopathy after exposure to low weekly doses in early pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

Pregnancy outcome of women exposed to azathioprine during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

7 January 2021

Advantages and problems with pregnancy registries: observations and surprises throughout the life of the International Lamotrigine Pregnancy Registry

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

7 January 2021

Half-life of the maternal IgG1 allotype in infants

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

7 January 2021

The effects of azathioprine on birth outcomes in women with inflammatory bowel disease (IBD)

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

7 January 2021

Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

7 January 2021

Medicines in Pregnancy-Women and Children First? Time for a Coalition to Address a Substantial Patient Need

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

7 January 2021

Drug use and breastfeeding

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-208840

7 January 2021